Last reviewed · How we verify
EV06 Ophthalmic Solution
At a glance
| Generic name | EV06 Ophthalmic Solution |
|---|---|
| Also known as | Active treatment |
| Sponsor | Encore Vision, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia. (PHASE2)
- A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia. (PHASE2)
- A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EV06 Ophthalmic Solution CI brief — competitive landscape report
- EV06 Ophthalmic Solution updates RSS · CI watch RSS
- Encore Vision, Inc. portfolio CI